Copyright ©ERS Journals Ltd 2002 Associations between markers of respiratory morbidity in European children1 Unit of Environmental Epidemiology, National Public Health Institute, Kuopio, Finland. 2 Harvard School of Public Health, Boston, MA, USA. 3 Dept of Occupational and Environmental Medicine, University Hospital, Lund, Sweden. 4 Environmental and Occupational Health Unit, University of Utrecht, Utrecht, The Netherlands CORRESPONDENCE: B. Brunekreef, Institute for Risk Assessment Sciences, Environmental and Occupational Health Group, PO Box 80176, 3508 TD, Utrecht, The Netherlands. Fax: 31 302535077. E-mail: b.brunekreef@iras.uu.nl Keywords: atopy, children, lung function, respiratory symptom
Received: October 6, 2000
This study was funded in the framework of the Commission of the European Communities Environment Programme, contracts EV5V-CT92-0220, CIPD-CT-92-5052 and ERBCIPD-CT-93-0046. K.L. Timonen was supported by grants from The Finnish Anti-Tuberculosis Association Foundation and The Ida Montin Foundation. The Finnish, Norwegian and two Swedish centres were funded by grants from the respective Governments.
School-aged children often experience acute respiratory symptoms. In a multicentre European study, the association between chronic respiratory symptoms (reported in a questionnaire), skin-prick test results, and lung function, and the occurrence of acute respiratory morbidity, was examined among children aged 612 yrs with chronic respiratory symptoms. Children with chronic respiratory symptoms, living in 10 European countries, were selected from a parent-completed questionnaire (n=4,307). Atopy was measured with skin-prick tests, and lung function with spirometry. A total of 1,854 (86% of those in the initial cohort) children kept a successful daily diary regarding their respiratory symptoms for 23 months. In multivariate logistic regression analyses, children with asthmatic symptoms, particularly those with doctor-diagnosed asthma, had a greater risk of occurrence of lower respiratory symptoms (odds ratio (OR): 6.12; 95% confidence interval (CI): 4.998.35) than children with a dry nocturnal cough as their only symptom. Atopy, particularly a positive reaction to indoor allergens, was significantly associated with occurrence of lower respiratory symptoms. For atopy the OR was 1.62 (95% CI: 1.341.96). A reduced level of maximal mid-expiratory flow was associated with an increased risk of lower respiratory symptoms, cough and phlegm. The associations were similar in Scandinavia, Central Eastern, Western and Southern Europe. To conclude, asthmatic symptoms reported in a questionnaire, atopic status and a reduced level of maximal mid-expiratory flow were associated with the occurrence of acute respiratory symptoms, especially those of lower respiratory symptoms. School-aged children often experience acute respiratory symptoms. However, few studies have examined the longitudinal relationship between host factors, such as atopy and lung function, and respiratory morbidity in children. Among these are the studies carried out in Southampton, UK 1, 2. In these studies, children with either wheeze or cough were followed-up over a year, by daily diaries. The main conclusion was that, although both atopy and symptoms of wheeze were associated with respiratory morbidity, a pre-existing doctor-diagnosis of asthma was the strongest predictive factor associated with more frequent and more severe lower respiratory symptom episodes, a greater proportion of symptomatic days, and a greater overall peak flow variability. Previously, it has been shown among children from the 10 European countries that, compared with children for whom only dry nocturnal cough was reported in the screening questionnaire, children with asthmatic symptoms had a greater diurnal and day-to-day variation in peak expiratory flow (PEF) during a 23 month follow-up. Moreover, atopy, especially positive reactions to indoor allergens, and a reduced level of lung function were also predictors of a greater variation in PEF 3. Therefore, the aim of the present study was to investigate whether these characteristics would also be associated with occurrence of acute respiratory symptoms during a 23 month, daily follow-up in this population.
Study locations The study was carried out within the framework of the Pollution Effects on Asthmatic Children in Europe (PEACE) project, which looks at the effects of air pollution on respiratory health of children. A total of 14 study centres in 10 countries took part in this European collaboration. The participating centres were, by the location of the urban area, Amsterdam (the Netherlands), Kuopio (Finland), Oslo (Norway), Berlin and Hettstedt (Germany), Pisa (Italy), Athens (Greece), Cracow and Katowice (Poland), Prague and Teplice (Czech Republic), Budapest (Hungary), Umeå and Malmö (Sweden). In each centre, the same study protocol was followed 4, 5. However, in Hettstedt, a different screening questionnaire was used for selection of subjects. Therefore, in the present analyses, data from 13 study centres are used, excluding Hettstedt.
Study design
Subjects
Screening questionnaire The screening questionnaire used in the PEACE study has been described previously 4, 5. A child was considered as eligible to enter the study if there was a positive response to at least one of the following questions: Has your child been bothered in the past 12 months by a wheezy chest, apart from colds? Has your child been bothered in the past 12 months by an attack of shortness of breath with wheezing? Has your child had dry cough at night in the past 12 months, apart from coughing with a cold or chest infection? Has a doctor ever said your child had asthma? 4, 5.
Skin-prick tests
Lung function tests
Symptom diaries
Definitions To study possible area differences within Europe, four regions were defined. The Finnish, Swedish and Norwegian centres formed "Scandinavia", the Polish, Czech and Hungarian centres formed "Central Eastern Europe", the German and Dutch centres formed "Western Europe", and the Italian and Greek centres formed "Southern Europe".
Statistical analyses In all models, adjustments were made for sex, age and study centre. In addition, when studying the effects of chronic respiratory symptoms reported in the screening questionnaire, adjustments were also made for atopy and level of lung function as maximal mid-expiratory flow (MMEF) (% from predicted). Similarly, when studying the effects of skin-prick test results, the models were also adjusted for chronic symptom status (having asthma or not) and level of lung function. Reactivity to house dust mite, cat and pollen allergens were included in the statistical model at the same time, to study the independent effects of these allergens. When studying the effects of spirometric lung function, adjustments were also made for atopy and chronic symptom status. The results are given as odds ratios (OR) with 95% confidence intervals (CI).
The mean±sd total number of follow-up days was 61.5±12.3 among children with cough alone and 63.0±12.4 among children with asthma. A total of 566 (31%) children had dry nocturnal cough apart from colds as their only chronic respiratory symptom (table 2
Compared to children with cough alone, children with asthma especially those with both symptoms and a doctor-diagnosis of asthma, more often reported all of the acute respiratory symptoms in the diary (table 2
Atopy was significantly associated with an increased risk of lower respiratory symptoms, but not with upper respiratory symptoms, cough or phlegm (table 2
The risk of lower respiratory symptoms rose as the number of positive reactions in the skin-prick test increased (fig. 2
In spirometric lung function measurements, a reduced level of MMEF was most strongly associated with acute respiratory symptoms reported in the diary (table 4
In this large epidemiological multicentre study among European children with chronic respiratory symptoms, chronic respiratory symptoms reported in a screening questionnaire, atopy and level of spirometric lung function were all independently associated with the proportion of days when acute respiratory symptoms, especially lower respiratory symptoms, were reported in a daily diary during a 23-month follow up. A doctor-diagnosed asthma with asthmatic symptoms during the past 12 months, positive reactions to indoor allergens (house dust mite or cat) and a reduced level of MMEF were most strongly associated with the occurrence of lower respiratory symptoms. The associations were similar in Scandinavia, Central Eastern, Western and Southern Europe. The effect estimates in the present study, however, may be too small. This is because, in the statistical models used, there were always variables for prior symptom status, level of lung function and reactivity to skin-prick tests. These factors are not, however, independent of each other. Therefore, by having all of these factors controlled for, the effects could have been underestimated. Chronic respiratory symptoms reported in the screening questionnaire were associated with the occurrence of acute respiratory symptoms during the 23 month, daily follow-up, especially the occurrence of lower respiratory symptoms. Compared to children with cough alone, children with asthma experienced lower and upper respiratory symptoms, and phlegm more often. The difference in reported cough during the follow-up was not so clear. Only children with both asthmatic symptoms during the past 12 months and doctor-diagnosed asthma reported cough more often than children with cough alone. In contrast to the study by Pattemore et al. 2, recent asthmatic symptoms were a better predictor of acute symptoms than a doctor's diagnosis of asthma. However, children with both the diagnosis and asthmatic symptoms experienced acute respiratory symptoms most often. A similar pattern for the occurrence of respiratory symptoms has been observed in previous studies. Peat et al. 9 initially studied a cohort of children with current asthma, wheeze only, or who were normal. Current asthma was defined as having both recent wheeze, assessed by a questionnaire, and bronchial hyperresponsiveness, assessed by a histamine challenge test. During the follow-up over a year, most children (93%) in the group of current asthma had wheeze, which was clearly more than among children in the wheeze-only group (52%). However, the latter group demonstrated more wheeze than the children in the normal group (18%). Among 650 children followed-up prospectively for 2 yrs. Children for whom current persistent wheeze was reported at the initial interview experienced more lower respiratory illness than children without current persistent wheeze at the initial interview 10. In contrast, no significant difference was found for upper respiratory illness. Clough et al. 1 studied children with wheeze or cough only, and with or without atopy. The symptom of wheeze was associated with a significantly greater severity of acute respiratory symptoms, but not with a greater proportion of days with lower respiratory tract symptoms, compared with cough as observed in the present study. Furthermore, unlike this study no interaction between atopy and wheeze was shown. In the subject selection phase of the study, one-half of the children asked, agreed to participate. This is a little less than in the follow-up study of Pattemore et al. 2 in which the response was 62%. It is possible that children, who had had more respiratory symptoms, would have been more likely to participate in the study. However, this selection would have led to more symptomatic children in all groups. Therefore, it is unlikely that the initial selection of subjects would have led to overestimation of the effects. In addition, if children with less severe chronic respiratory symptoms, e.g. cough alone, were less motivated to fill in the diary when free of symptoms, the proportion of days with acute respiratory symptoms would have been overestimated. This would lead to attenuation in the difference between children with asthma and with cough alone. In the present study, this is not likely. A child had to have >60% of the days with valid data to be included in the analyses. Moreover, there was no difference in the total number of reporting days between children having asthma and children with cough alone. Atopy, and especially a positive reaction to house dust mite and cat were significantly associated with the occurrence of lower respiratory symptoms. These results are supported by previous studies. In their study among children with cough or wheeze, Clough et al. 1 demonstrated that when controlling for the symptom of wheeze, atopy was associated with a significantly greater proportion of days with symptoms than the absence of atopy, during a follow-up over a year. Henderson et al. 11 examined correlates of recent wheezing episodes in a case-control study among children. In that study, sensitization to house dust mite was consistently associated with recurrent wheezing episodes, with an OR of 5.2 (95% CI: 3.09.0), whereas no evidence that pollen allergy contributed significantly to susceptibility to recurrent wheezing episodes was provided. Previously, it has been stated that sensitivity to house dust mite and to cat dander is closely associated with current asthma in children, whereas grass sensitivity is not a significant independent risk factor for asthma 12. This was further supported by the present study. These results confirm the important role indoor allergens play in the occurrence of asthmatic symptoms. However, since this study was confined to the winter time, when children were little exposed to pollen, a role for pollen in the occurrence of acute respiratory symptoms cannot be ruled out. There was no clear pattern in the association between the level of FVC and the occurrence of acute respiratory symptoms. A reduced level in FEV1 was positively associated with the occurrence of respiratory symptoms, but was significant only with the occurrence of phlegm. A low level of FEV1/FVC was significantly associated with lower respiratory symptoms as well as phlegm. Conversely, a reduced level of MMEF was significantly associated with lower respiratory symptoms, cough and phlegm. This finding together with the previous results, in which a reduced level of MMEF was closely associated with asthmatic symptoms, positive reactions to indoor allergens, and a greater PEF variability, supports MMEF as a sensitive parameter of airway obstruction 13. MMEF is effort independent and measures flow predominantly in the peripheral airways, whereas FEV1 measures airflow predominantly in the central airway. Therefore, MMEF might be reduced while asymptomatic or in an earlier stage than FEV1. It is noteworthy that in addition to the level of lung function, positive reactions to house dust mite and cat, and a doctor-diagnosis of asthma with symptoms in the past 12 months were also strongly associated with phlegm in this study. Phlegm is not a classical asthmatic symptom, but clearly in this study, it responds to the same risk factors as more traditional symptoms like wheezing. The present multicentre study is the first focused on associations between chronic respiratory symptoms, skin test results and lung function, and acute respiratory morbidity in different European regions. In all four regions, the associations between chronic respiratory symptoms, atopy, lung function and acute respiratory morbidity were similar among symptomatic children. To conclude, asthmatic symptoms (reported in a questionnaire), atopy (especially a positive reaction to house dust mite and cat), and a reduced level of maximal mid-expiratory flow were associated with the occurrence of acute respiratory symptoms specifically lower respiratory symptoms, during the 23-month follow-up.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||